Literature DB >> 8915662

Hypogonadotropic patients with ultrasonographically detected polycystic ovaries: endocrine response to pulsatile gonadotropin-releasing hormone.

M Schachter1, A H Balen, A Patel, H S Jacobs.   

Abstract

To characterize the endocrine response during induction of ovulation in patients with hypogonadotropic hypogonadism and ultrasound findings of polycystic ovary, we performed a retrospective analysis of 22 treatment cycles with pulsatile gonadotropin-releasing hormone (GnRH) in such patients and of 17 treatment cycles in similar patients with ultrasonographically normal ovaries. Of the 21 patients studies, 11 had an ultrasound finding of polycystic ovaries and ten had ovaries that appeared normal. Serum luteinizing hormone (LH), follicle-stimulating hormone (FSH) and estradiol levels, number of follicles of diameter > 12 mm (by ultrasound), and ovulation and conception rates were measured. Patients with hypogonadotropic hypogonadism and ultrasound-diagnosed polycystic ovary had pretreatment endocrine status similar to those with normal ovaries, but had much higher baseline ovarian volume. Ovulation induction with pulsatile GnRH induced much higher serum LH concentrations in the former group despite similar FSH levels. This difference preceded any change in estradiol levels. The former group consistently recruited significantly more follicles during pulsatile GnRH treatment. However, ovulation and conception rates were (non-significantly) higher in the latter group. In conclusion, this study characterized a subgroup of hypogonadotropic patients with ovarian morphology, volume and response to ovulation induction similar to in patients with polycystic ovary syndrome. When treated with pulsatile GnRH, those with polycystic ovary significantly hypersecreted LH before their estradiol level changed significantly. The primary lesion in polycystic ovary syndrome seems to be in the ovary, with pituitary hypersecretion of LH secondary to disturbed ovarian feedback signalling.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8915662     DOI: 10.3109/09513599609012819

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  6 in total

Review 1.  Gonadotropin surge-inhibiting/attenuating factors: a review of current evidence, potential applications, and future directions for research.

Authors:  Mario G Vega; Shvetha M Zarek; Medha Bhagwat; James H Segars
Journal:  Mol Reprod Dev       Date:  2015-01-12       Impact factor: 2.609

Review 2.  PCOS Forum: research in polycystic ovary syndrome today and tomorrow.

Authors:  Renato Pasquali; Elisabet Stener-Victorin; Bulent O Yildiz; Antoni J Duleba; Kathleen Hoeger; Helen Mason; Roy Homburg; Theresa Hickey; Steve Franks; Juha S Tapanainen; Adam Balen; David H Abbott; Evanthia Diamanti-Kandarakis; Richard S Legro
Journal:  Clin Endocrinol (Oxf)       Date:  2011-04       Impact factor: 3.478

3.  Is Ovarian Reserve Impacted in Anorexia Nervosa?

Authors:  Sarah Pitts; Suzanne E Dahlberg; Jenny Sadler Gallagher; Catherine M Gordon; Amy D DiVasta
Journal:  J Pediatr Adolesc Gynecol       Date:  2020-12-03       Impact factor: 1.814

4.  Fine particulate matter and polycystic ovarian morphology.

Authors:  Shruthi Mahalingaiah; Kevin J Lane; Victoria Fruh; Jay Jojo Cheng; Ann Aschengrau
Journal:  Environ Health       Date:  2022-02-18       Impact factor: 5.984

5.  Direct actions of androgen, estrogen and anti-Müllerian hormone on primate secondary follicle development in the absence of FSH in vitro.

Authors:  T Baba; A Y Ting; O Tkachenko; J Xu; R L Stouffer
Journal:  Hum Reprod       Date:  2017-12-01       Impact factor: 6.918

6.  Does polycystic ovarian morphology influence the response to treatment with pulsatile GnRH in functional hypothalamic amenorrhea?

Authors:  Agathe Dumont; Didier Dewailly; Pauline Plouvier; Sophie Catteau-Jonard; Geoffroy Robin
Journal:  Reprod Biol Endocrinol       Date:  2016-04-29       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.